High prevalence of muscle weakness and probable sarcopenia in patients with inflammatory bowel disease
- PMID: 38321633
- DOI: 10.1002/ncp.11125
High prevalence of muscle weakness and probable sarcopenia in patients with inflammatory bowel disease
Abstract
Background: This study aimed to determine the prevalence of probable sarcopenia and sarcopenia in patients with inflammatory bowel disease (IBD) by using the European Working Group on Sarcopenia in Older People (EWGSOP2) diagnostic criteria.
Methods: Sarcopenia was assessed by using the sequential four-step algorithm. (1) Find: Sarcopenia risk by simple clinical symptom index (strength, assistance walking, rise from a chair, climb stairs, and falls [SARC-F questionnaire]). (2) Assess: Probable sarcopenia by low muscle strength on handgrip. (3) Confirm: Confirmed sarcopenia by low appendicular skeletal muscle mass on bioimpedance analysis. (4) Severity: Severe sarcopenia by low 4-m gait speed test.
Results: A total of 129 adult patients with IBD younger than 65 years and 50 age- and sex-matched healthy control (HC) participants were included to the study. Handgrip strength, gait speed, and SARC-F scores were significantly lower in patients with IBD than in the HCs (P = 0.032, <0.0001, and <0.0001, respectively). Based on the EWGSOP2 definition, 17.8% of patients with IBD had probable sarcopenia, and six patients had confirmed sarcopenia. According to the ethnicity-based population thresholds, 34.9% of patients with IBD had probable sarcopenia, and two patients had confirmed sarcopenia. Corticosteroid use within the past year was identified as an independent risk factor for low muscle strength (P = 0.012; odds ratio, 4.133), along with advanced age and disease activity.
Conclusion: One-third of the patients younger than 65 years with IBD had probable sarcopenia, defined as low muscle strength, whereas the incidence of confirmed sarcopenia remained relatively low.
Keywords: bioelectric impedance analysis; handgrip; inflammatory bowel disease; muscle strength; probable sarcopenia; sarcopenia.
© 2024 American Society for Parenteral and Enteral Nutrition.
References
REFERENCES
-
- Kani HT, Ergenc İ, Arikan H, et al. Validation and reliability of the Turkish version of the inflammatory bowel disease questionnaire for ulcerative colitis and Crohn's disease. Turk J Gastroenterol. 2020;31(8):566‐572.
-
- Lin A, Micic D. Nutrition considerations in inflammatory bowel disease. Nutr Clin Pract. 2021;36(2):298‐311.
-
- Valentini L, Schaper L, Buning C, et al. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Nutrition. 2008;24(7‐8):694‐702.
-
- Singh A, Midha V, Mahajan R, et al. Evaluation of nutritional characteristics reveals similar prevalence of malnutrition in patients with ulcerative colitis and Crohn's disease. Dig Dis Sci. 2023;68(2):580‐595.
-
- Lee S‐Y, Tung HH, Liu C‐Y, Chen LK. Physical activity and sarcopenia in the geriatric population: a systematic review. J Am Med Dir Assoc. 2018;19(5):378‐383.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
